Plasmacytoid dendritic cells reduce HIV production in elite controllers

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• HIV elite controllers (ECs) spontaneously control viral load without treatment, but the mechanisms remain incompletely understood.
• Adaptive immunity and host genetics don't fully explain HIV control in ECs.
• Plasmacytoid dendritic cells (pDCs) are key producers of type I interferon (IFN) during viral infections, but their role in ECs is unclear.

Purpose of the Study:

• To investigate the role of pDCs in HIV elite controllers.
• To compare pDC levels and function in ECs versus other HIV-infected groups.
• To explore the mechanisms by which pDCs might control HIV viremia.

Main Methods:

• Analysis of peripheral pDC counts and IFN-α production by peripheral blood mononuclear cells (PBMCs) in ECs and other HIV-infected patient groups.
• In vitro assessment of pDC capacity to reduce HIV production.
• Investigation of mechanisms involved in pDC-mediated HIV control, including T cell apoptosis induction.

Main Results:

• ECs exhibit preserved pDC counts and IFN-α production.
• pDCs from ECs demonstrate a greater ability to reduce HIV production and induce T cell apoptosis compared to viremic patients.
• pDCs from viremic patients showed limited response without Toll-like receptor 9 (TLR-9) stimulation.

Conclusions:

• Preserved pDC functionality in ECs may contribute to the control of HIV viremia.
• Innate immunity, particularly pDCs, plays a significant role in HIV pathogenesis.
• Understanding pDC mechanisms could inform the development of novel HIV therapies.